S. Stahl, United States of America

Dr. Stahl held faculty positions at Stanford University, the University of California, the Institute of Psychiatry London, the Institute of Neurology London, and was formerly Executive Director of Clinical Neurosciences at the Merck Neuroscience Research Center in the UK. Currently he is professor at the University of California at San Diego, Honorary Visiting Senior Fellow in the Department of Psychiatry at the University of Cambridge and Director of Psychopharmacology Services and Senior Academic Advisor of California Department of State Hospitals. He is the Chairman of Neuroscience Education Institute and Arbor Scientia Group. He serves as a fellow of the American College of Neuropsychopharmacology, of the British Association of Psychopharmacology and of the CINP, and is a Distinguished Life Fellow of the American Psychiatric Association. He is editor-in-chief of CNS Spectrums and is on numerous editorial boards of other leading journals. Author of over 500 articles, winer of several scientific awards.

Presenter Of 2 Presentations

Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

The role of partial dopamine agonists at the dawn of psychosis

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 2
Lecture Time
19:05 - 19:30
Industry Session not Included in the Main Event CME / CPD Credit (ID 1116) No Topic Needed

Live Q&A

Session Icon
Pre-Recorded with Live Q&A
Date
Sat, 10.04.2021
Session Time
19:00 - 20:30
Room
Industry 2
Lecture Time
20:20 - 20:30